Advanced or Metastatic Breast Cancer
1 competing product in clinical development for Advanced or Metastatic Breast Cancer.
Pipeline by Phase
Phase 31
All Products (1)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Trastuzumab deruxtecan + Capecitabine + Paclitaxel + Nab-Paclitaxel | Daiichi Sankyo | Phase 3 | Active | 44 |